Application and Interpretation of an Interferon-Gamma Release Assay: Results of an Audit in a Canadian Centre | Zendy

Sopharat Vat | Zendy; Marc Ghannoum | Zendy; Pierre Laflamme | Zendy; Mario Dugas | Zendy; Ma Labrecque | Zendy; Valéry Lavergne | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Application and Interpretation of an Interferon-Gamma Release Assay: Results of an Audit in a Canadian Centre

Author(s) -

Sopharat Vat,

Marc Ghannoum,

Pierre Laflamme,

Mario Dugas,

Ma Labrecque,

Valéry Lavergne

Publication year - 2012

Publication title -

canadian journal of infectious diseases and medical microbiology

Language(s) - English

Resource type - Journals

eISSN - 1918-1493

pISSN - 1712-9532

DOI - 10.1155/2012/838465

Subject(s) - tuberculin , medicine , concordance , latent tuberculosis , skin test , audit , interferon gamma release assay , tuberculosis , test (biology) , quantiferon , mycobacterium tuberculosis , pathology , management , economics , paleontology , biology

Interferon-gamma release assays (IGRAs) are newly approved for diagnosing latent tuberculosis infection (LTBI). An internal audit was conducted to review the use of a newly implemented IGRA at the Hôpital du Sacré-Coeur de Montréal (Montréal, Québec) to evaluate its concordance with Canadian recommendations and its implication on diagnosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research